The anti-platelet approach targeting the
โ
Vassilios Tsikaris
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 454 KB
## Abstract Activation of the platelet surface receptor GPIIb/IIIa is the final pathway of platelet aggregation, regardless of the initiating stimulus. RGD analogues, peptidomimetics and monoclonal antibodies to GPIIb/IIIa have been developed targeting the blockage of the receptor and inhibition of